TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7036799

Group type: EXPERIMENTAL
Intervention: 0.5 per cent bupivacaine HCl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 per cent lidocaine HCl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lidocaine-bupivacaine mixture (1:3)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lidocaine-bupivacaine mixture (1:1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lidocaine-bupivacaine mixture (3:1)
Number of subjects: 60
Study: 30915491

Group type: COMPARATOR
Intervention: 5 cycles of sham conditioning
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3 cycles of RLIC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4 cycles of RLIC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5 cycles of RLIC
Number of subjects: 40
Study: 29129252

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 360

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 360
Study: 26645407

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) trastuzumab 600 mg
Number of subjects: 595

Group type: COMPARATOR
Intervention: Intravenous (IV) trastuzumab (weight-based)
Number of subjects: 595
Study: 25551934

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 80
Study: 22750044

Group type: EXPERIMENTAL
Intervention: Text message immunization reminders prior to immunization due dates
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 90
Study: 20465344

Group type: EXPERIMENTAL
Intervention: Culture-sensitive prevention programs
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Transcultural perspectives on suicidal behaviors
Number of subjects: 19
Study: 19134350

Group type: EXPERIMENTAL
Intervention: Group G (puberty gingivitis)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group P (chronic periodontitis)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Group H (healthy controls)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mild-moderate group
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Severe inflammation group
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Severe gingivitis group
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 54
Study: 15865498

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rest (control)
Number of subjects: 50
Study: 12876091

Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg three times a day
Number of subjects: 1368

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1368
Study: 10554851

Group type: EXPERIMENTAL
Intervention: Surgery for thoracic aortic aneurysm in patients aged 70 years or older
Number of subjects: 261
Study: 9097988

Group type: EXPERIMENTAL
Intervention: Mesalamine (750 mg four times a day for 48 weeks)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Mesalamine
Number of subjects: 293
Study: 1288906

Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: COMPARATOR
Intervention: EMLA/Placebo
Number of subjects: 34
Study: 3010696

Group type: EXPERIMENTAL
Intervention: THC
Number of subjects: 139

Group type: COMPARATOR
Intervention: Compazine
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: THC and Compazine
Number of subjects: 139
Study: 30882555

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Efavirenz (EFV)
Number of subjects: 0
Study: 30415664

Group type: EXPERIMENTAL
Intervention: Unlocked Group (UG)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Dynamic Group (DG)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Static Group (SG)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: All Groups
Number of subjects: 240
Study: 27998900

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice
Number of subjects: 246

Group type: COMPARATOR
Intervention: Nitrate-deplete beetroot juice (placebo)
Number of subjects: 246
Study: 25263513

Group type: EXPERIMENTAL
Intervention: Pharyngeal cooling
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard care without pharyngeal cooling
Number of subjects: 108
Study: 22284965

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis GCL2505
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 18814805

Group type: EXPERIMENTAL
Intervention: Dietary glycaemic index (GI)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Dietary glycaemic load (GL)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Increasing GI
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: GL
Number of subjects: 29133
Study: 17907289

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin, 5-FU, and enteric-coated tegafur/uracil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy
Number of subjects: 10
Study: 15167313

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (while continuing 2.5 mg of oral medroxyprogesterone acetate)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Oral estrogen (0.625 mg of conjugated equine estrogen plus 2.5 mg of medroxyprogesterone acetate)
Number of subjects: 61
Study: 11181465

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/d for 3 months
Number of subjects: 24
Study: 8485792

Group type: EXPERIMENTAL
Intervention: Orogastric tube aspiration
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control (no tube inserted)
Number of subjects: 265
Study: 3326743

Group type: EXPERIMENTAL
Intervention: 3 Lf diphtheria vaccine
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 7.5 Lf diphtheria vaccine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 200
Study: 29268022

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection into the rotator interval (RI)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection into the intra-articular (IA) space
Number of subjects: 77

Group type: COMPARATOR
Intervention: Corticosteroid injection into the subacromial (SA) space
Number of subjects: 77
Study: 28577840

Group type: EXPERIMENTAL
Intervention: WATCHMAN implant
Number of subjects: 1025
Study: 24391022

Group type: EXPERIMENTAL
Intervention: GOLD sequence (free-breathing)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: PPI treatment
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard breath-hold gradient echo sequence
Number of subjects: 23
Study: 23216382

Group type: EXPERIMENTAL
Intervention: Rifaximin (1200 mg/day)
Number of subjects: 23
Study: 22010585

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 82

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 82
Study: 18309140

Group type: EXPERIMENTAL
Intervention: US-born Black women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Black West Indian men
Number of subjects: 0

Group type: COMPARATOR
Intervention: Black West Indian women
Number of subjects: 0
Study: 16448518

Group type: EXPERIMENTAL
Intervention: Packaged portion‐controlled entrees (Group E, n = 25)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Self‐selected diet (Group P, n = 26)
Number of subjects: 60
Study: 12624861

Group type: EXPERIMENTAL
Intervention: Tiredness Management Guide (TMG)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study: 11099709

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 9496207

Group type: EXPERIMENTAL
Intervention: Pre-incisional extradural analgesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: No pre-incisional extradural analgesia (Control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Post-extradural analgesia during operation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups during emergence from anaesthesia
Number of subjects: 20
Study: 8211679

Group type: EXPERIMENTAL
Intervention: Proximal splenorenal shunt (PSRS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt (DSRS)
Number of subjects: 48
Study: 3669757

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid alpha-interferon (3 mega units daily subcutaneously until complete or partial response)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Maintenance regime of 3 mega units/week
Number of subjects: 82

Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid alpha-interferon
Number of subjects: 82
Study: 31781921

Group type: EXPERIMENTAL
Intervention: Mirrored images of the left femur using the right as a template
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3D Trauma and CT motion analysis (CTMA)
Number of subjects: 10
Study: 29565302

Group type: EXPERIMENTAL
Intervention: UNICEF Laos WinS project
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily group hygiene activities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complementary strategy for individual handwashing practice
Number of subjects: 0
Study: 27837658

Group type: EXPERIMENTAL
Intervention: OLZ/ZIP (switch from olanzapine to ziprasidone after 4 weeks)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: OLZ + ZIP (combination therapy)
Number of subjects: 148

Group type: COMPARATOR
Intervention: ZIP (ziprasidone monotherapy)
Number of subjects: 148

Group type: COMPARATOR
Intervention: OLZ (olanzapine monotherapy)
Number of subjects: 148
Study: 25424689

Group type: EXPERIMENTAL
Intervention: Perindopril 2 mg plus lercanidipine 5 mg (Group A)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Lercanidipine 10 mg (Group B)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Perindopril 4 mg (Group C)
Number of subjects: 180
Study: 24034661

Group type: EXPERIMENTAL
Intervention: Valsartan 80 mg/d
Number of subjects: 1978
Study: 21883574

Group type: EXPERIMENTAL
Intervention: Ecological approach intervention including a two-hour seminar and a brochure about health and development during puberty
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 228
Study: 19398081

Group type: EXPERIMENTAL
Intervention: Physical training (n = 27)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (n = 27)
Number of subjects: 54
Study: 17957418

Group type: EXPERIMENTAL
Intervention: Remote simultaneous medical interpreting (RSMI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Proximate ad hoc interpreting
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-RSMI encounters
Number of subjects: 22
Study: 15050265

Group type: EXPERIMENTAL
Intervention: Nagahara phaco‐chop technique (Group 1)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Stop-and-chop technique (Group 2)
Number of subjects: 70
Study: 11348939

Group type: EXPERIMENTAL
Intervention: SR bupropion treatment (100, 150, or 300 mg/d) for 7 weeks
Number of subjects: 615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study: 8989016

Group type: EXPERIMENTAL
Intervention: Atropine 20 micrograms/kg and neostigmine 50 micrograms/kg (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 8 micrograms/kg and neostigmine 50 micrograms/kg (Group G)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (Group P)
Number of subjects: 30
Study: 8484510

Group type: EXPERIMENTAL
Intervention: Isoflurane (0.8% and 1.2%)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Propofol (approximately 3 micrograms/mL) with 60% nitrous oxide
Number of subjects: 13

Group type: COMPARATOR
Intervention: Esmolol infusion (100 micrograms.kg-1 x min-1) during propofol anesthesia
Number of subjects: 13
Study: 3117150

Group type: EXPERIMENTAL
Intervention: Nebulizer administration of 4 mg terbutaline
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nebuhaler administration of 4 mg terbutaline
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (chronic hypoxia patients)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normoxic patients)
Number of subjects: 20
Study: 28449618

Group type: EXPERIMENTAL
Intervention: Telerehabilitation programme
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (usual face‐to‐face physical therapy)
Number of subjects: 18
Study: 27560663

Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 3043

Group type: COMPARATOR
Intervention: Secondhand smoke (SHS) exposure at home
Number of subjects: 3043
Study: 24506666

Group type: EXPERIMENTAL
Intervention: MAL‐PDT
Number of subjects: 200

Group type: COMPARATOR
Intervention: DHA
Number of subjects: 200
Study: 23510581

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 20502134

Group type: EXPERIMENTAL
Intervention: Sublingual tizanidine HCl (8 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oral tizanidine HCl (8 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 20071812

Group type: EXPERIMENTAL
Intervention: Closed reduction and long arm posterior slab application (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Closed reduction and percutaneous crossed Kirschner wires fixation (Group B)
Number of subjects: 60
Study: 16480168

Group type: EXPERIMENTAL
Intervention: Tiagabine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Benzodiazepines (oxazepam and lorazepam)
Number of subjects: 13
Study: 14530224

Group type: EXPERIMENTAL
Intervention: Rofecoxib, 25 mg/d
Number of subjects: 5557

Group type: COMPARATOR
Intervention: Naproxen, 500 mg twice daily
Number of subjects: 5557
Study: 10346072

Group type: EXPERIMENTAL
Intervention: School-based social competency promotion program
Number of subjects: 0
Study: 8965294

Group type: EXPERIMENTAL
Intervention: ISIS group (IG) - received a 30 to 60 min session on the computer in addition to standard cardiovascular education.
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (CG) - received standard cardiovascular education only.
Number of subjects: 158
Study: 2000833

Group type: EXPERIMENTAL
Intervention: High-sodium polymeric-glucose solution (maltodextrins 18 g Glucidex 12/L + 2.5 g NaCl/L)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard oral rehydration solution
Number of subjects: 6
Study: 6510015

Group type: EXPERIMENTAL
Intervention: 0.05% diflorasone diacetate ointment, once a day
Number of subjects: 70

Group type: COMPARATOR
Intervention: 0.1% betamethasone valerate ointment, twice a day
Number of subjects: 70
Study: 30481110

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) administration of MMRV vaccine
Number of subjects: 405

Group type: COMPARATOR
Intervention: Subcutaneous (SC) administration of MMRV vaccine
Number of subjects: 405
Study: 29296999

Group type: EXPERIMENTAL
Intervention: 3-D stent retriever with aspiration
Number of subjects: 198

Group type: COMPARATOR
Intervention: Aspiration alone
Number of subjects: 198
Study: 26771705

Group type: EXPERIMENTAL
Intervention: Simulated night work (circadian misalignment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simulated day work (circadian alignment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circadian misalignment
Number of subjects: 0
Study: 24347351

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.2 mg
Number of subjects: 66

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 66
Study: 22972032

Group type: EXPERIMENTAL
Intervention: Prednisone 15 mg daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prednisone 7.5 mg daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 20632513

Group type: EXPERIMENTAL
Intervention: Core decompression combined with autologous bone marrow mesenchymal stem cells (BMSCs) transplantation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Core decompression alone
Number of subjects: 8
Study: 18046293

Group type: EXPERIMENTAL
Intervention: Propofol (20 mg bolus and 1.0 mg x kg(‐1) x h(‐1) infusion)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Midazolam (1 mg bolus and 1.0 mg x h(‐1) infusion)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 90
Study: 15531670

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HIE)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (LIE)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 13
Study: 11679459

Group type: EXPERIMENTAL
Intervention: Monitoring condition (psychological well-being assessment by diabetes nurse specialist)
Number of subjects: 461

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Monitoring condition
Number of subjects: 461
Study: 9931805

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy without conversion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparotomy conversion
Number of subjects: 0
Study: 7825408

Group type: EXPERIMENTAL
Intervention: Topical cyclosporin 2% in olive oil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (sterile olive oil)
Number of subjects: 30
Study: 2449651

Group type: EXPERIMENTAL
Intervention: Gamma-globulin infusion (GG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Aspirin only (Control)
Number of subjects: 29
Study: 31036259

Group type: EXPERIMENTAL
Intervention: Reminder + Tetris
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Reminder + Quiz
Number of subjects: 86

Group type: COMPARATOR
Intervention: Reminder-only
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 86
Study: 31236580

Group type: EXPERIMENTAL
Intervention: EULAR SS Patients Reported Index (ESSPRI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EULAR SS Disease Activity Index (ESSDAI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Objective measures for ocular and oral dryness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New targeted therapies
Number of subjects: 0
Study: 28641122

Group type: EXPERIMENTAL
Intervention: 6-session parent-focused intervention (Fear-less Triple P)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wait-list control (WL) group
Number of subjects: 61
Study: 26475054

Group type: EXPERIMENTAL
Intervention: Albuterol MDPI (180 μg, 2 inhalations of 90 μg each)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo MDPI
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Albuterol MDPI
Number of subjects: 38
Study: 23075427

Group type: EXPERIMENTAL
Intervention: Exercise while viewing natural scenes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Exercise while viewing built scenes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 25
Study: 21785892

Group type: EXPERIMENTAL
Intervention: Behavioral risks screening (smoking, environmental tobacco smoke exposure, depression, intimate partner violence)
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: CART analysis
Number of subjects: 1044
Study: 19103889

Group type: EXPERIMENTAL
Intervention: Gonovaccine provocation
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control (no provocation)
Number of subjects: 204
Study: 16352728

Group type: EXPERIMENTAL
Intervention: Real-time functional MRI (rtfMRI) training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham rtfMRI training
Number of subjects: 0

Group type: COMPARATOR
Intervention: rtfMRI information from a different brain region
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training without rtfMRI information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rtfMRI training in chronic pain patients
Number of subjects: 0
Study: 12213081

Group type: EXPERIMENTAL
Intervention: Different types of music
Number of subjects: 60

Group type: COMPARATOR
Intervention: Silence
Number of subjects: 60
Study: 9579447

Group type: EXPERIMENTAL
Intervention: Nonclosure of the peritoneum
Number of subjects: 144

Group type: COMPARATOR
Intervention: Closed peritoneum (control)
Number of subjects: 144
Study: 7898828

Group type: EXPERIMENTAL
Intervention: Esterified estrogens (1.25 mg) and methyltestosterone (2.5 mg) daily for 2 years
Number of subjects: 66

Group type: COMPARATOR
Intervention: Esterified estrogens (1.25 mg) daily for 2 years
Number of subjects: 66
Study: 2523827

Group type: EXPERIMENTAL
Intervention: doxycycline/bensylpenicillin‐procain (DC/BP)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: trimethoprim‐sulfamethoxazole (TMP‐SMZ)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 64
Study: 19230

Group type: EXPERIMENTAL
Intervention: Sultopride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thioproperazine
Number of subjects: 0
Study: 31017822

Group type: EXPERIMENTAL
Intervention: ACT017 (doses ranging from 62.5 to 2000 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ACT017
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 27557937

Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate citrate (2.5, 5.0, 7.5, or 10 mg administered over 4 hours; 15 or 20 mg administered over 12 hours)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate citrate
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 26114609

Group type: EXPERIMENTAL
Intervention: Fatigue of the soleus muscle (SOL)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fatigue of the gastrocnemius lateralis muscle (GL)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fatigue of the gastrocnemius medialis muscle (GM)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Maximal voluntary torque
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Synergistic voluntary muscle activity
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Spinal reflex activity (H-reflex)
Number of subjects: 11
Study: 24118688

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 469

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg and 300 mg
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 469
Study: 22333443

Group type: EXPERIMENTAL
Intervention: Computer Assisted Minimally Invasive Spine Surgery (CAMISS)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Traditional Open Surgery (Control)
Number of subjects: 97